Galmed Pharmaceuticals Ltd.
13F holders, Q2 2024 (June 30)13holders
1new positions
1sold out
$0.28avg. 13F price*
At the end of Q2 2024, 13 institutions reported holding Galmed Pharmaceuticals Ltd. in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 1 sold out. The largest holders were Walleye Capital LLC ($83K), CVI Holdings, LLC ($14K) and Morgan Stanley ($10K).
- Company
- Galmed Pharmaceuticals Ltd.
- CUSIP
- M47238122
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $3K |
| Exits | 1 | $8K |
All 13F filers, Q1 2024 → Q2 2024: 281,924 shares bought and 57,649 shares sold, net +224,275 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Walleye Capital LLC | 0.00% | Add +591.7% | 290,596 | $83K |
| CVI Holdings, LLC | 0.01% | Reduce -36.7% | 47,239 | $14K |
| Morgan Stanley | 0.00% | Add +149.8% | 36,213 | $10K |
| Susquehanna International Group, LLP | 0.00% | New | 11,625 | $3K |
| Two Sigma Securities, LLC | 0.00% | Reduce -36.6% | 10,330 | $3K |
| UBS Group AG | 0.00% | Reduce -87.6% | 280 | $77 |
| Wells Fargo & Company | 0.00% | No change | 204 | $56 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 167 | $46 |
| Osaic Holdings, Inc. | 0.00% | No change | 53 | $14 |
| Allworth Financial LP | 0.00% | No change | 17 | $6 |
| Elevation Wealth Partners, LLC | 0.00% | No change | 7 | $2 |
| Bank of America Corp. | 0.00% | No change | 1 | $0 |
| Tsfg, LLC | 0.00% | No change | 200 | $0 |
"% of holder's portfolio" is GALMED PHARMACEUTICALS LTD's weight in each manager's 13F, not the share of Galmed Pharmaceuticals Ltd. the manager owns.